Clusters of Circulating let-7 Family Tumor Suppressors Are Associated with Clinical Characteristics of Chronic Hepatitis C
暂无分享,去创建一个
Ming‐Lung Yu | M. Yeh | Chung‐Feng Huang | Ching-I. Huang | C. Dai | Po-Cheng Liang | M. Hsieh | Zu-Yau Lin | Jee-Fu Huang | W. Chuang | Y. Tsai | Shinn-Cherng Chen | Pei-Chien Tsai | Yi-Hung Lin | Ta-Wei Liu | M. Yu | Yi‐Hung Lin | Ching‐I. Huang | Ching-I Huang | Jee‐Fu Huang | Chung-Feng Huang | Ming‐Lung Yu
[1] Mary Goldman,et al. The UCSC Xena platform for public and private cancer genomics data visualization and interpretation , 2018, bioRxiv.
[2] Xiaowei Wang,et al. OncomiR: an online resource for exploring pan-cancer microRNA dysregulation , 2018, Bioinform..
[3] G. Dore,et al. Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regression. , 2017, Journal of hepatology.
[4] Y. Hoshida,et al. Hepatitis C-related hepatocellular carcinoma in the era of new generation antivirals , 2017, BMC Medicine.
[5] Chien-Jen Chen,et al. Risk of hepatitis C virus related hepatocellular carcinoma between subjects with spontaneous and treatment-induced viral clearance , 2017, Oncotarget.
[6] K. Matsuura,et al. Circulating let‐7 levels in plasma and extracellular vesicles correlate with hepatic fibrosis progression in chronic hepatitis C , 2016, Hepatology.
[7] S. Lheureux,et al. Towards a new standardized method for circulating miRNAs profiling in clinical studies: Interest of the exogenous normalization to improve miRNA signature accuracy , 2016, Molecular oncology.
[8] S. Juo,et al. MicroRNA let-7g cooperates with interferon/ribavirin to repress hepatitis C virus replication , 2016, Journal of Molecular Medicine.
[9] R. Thimme,et al. Suppressive effect of interleukin 10 on priming of naive hepatitis C virus-specific CD8+ T cells. , 2015, The Journal of infectious diseases.
[10] T. Luedde,et al. Circulating microRNAs as markers of liver inflammation, fibrosis and cancer. , 2014, Journal of hepatology.
[11] N. Bardeesy,et al. Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma. , 2014, Journal of hepatology.
[12] M. Yeh,et al. Baseline gamma-glutamyl transferase levels strongly correlate with hepatocellular carcinoma development in non-cirrhotic patients with successful hepatitis C virus eradication. , 2014, Journal of hepatology.
[13] A. Sanyal,et al. Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis , 2014, Gut.
[14] S. Juo,et al. Peripheral blood mononuclear cells microRNA predicts treatment outcome of hepatitis C virus genotype 1 infection. , 2014, Antiviral research.
[15] Q. Jin,et al. High-Throughput Profiling of Alpha Interferon- and Interleukin-28B-Regulated MicroRNAs and Identification of let-7s with Anti-Hepatitis C Virus Activity by Targeting IGF2BP1 , 2013, Journal of Virology.
[16] G. Reid,et al. The Impact of Hemolysis on Cell-Free microRNA Biomarkers , 2013, Front. Genet..
[17] G. Teng,et al. Let-7b Is Involved in the Inflammation and Immune Responses Associated with Helicobacter pylori Infection by Targeting Toll-Like Receptor 4 , 2013, PloS one.
[18] Chien-Jen Chen,et al. Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: a community-based long-term prospective study. , 2012, The Journal of infectious diseases.
[19] D. Cooper,et al. Differential Regulation of the Let-7 Family of MicroRNAs in CD4+ T Cells Alters IL-10 Expression , 2012, The Journal of Immunology.
[20] P. Jansen,et al. Diagnostic and therapeutic potential of miRNA signatures in patients with hepatocellular carcinoma. , 2012, Journal of hepatology.
[21] S. Morini,et al. Toll-like receptor-4 expression by hepatic progenitor cells and biliary epithelial cells in HCV-related chronic liver disease , 2012, Modern Pathology.
[22] Hsien-Da Huang,et al. Let-7b is a novel regulator of hepatitis C virus replication , 2012, Cellular and Molecular Life Sciences.
[23] J. Clements,et al. Relationships of PBMC microRNA expression, plasma viral load, and CD4+ T-cell count in HIV-1-infected elite suppressors and viremic patients , 2012, Retrovirology.
[24] R. Gregory,et al. Molecular Basis for Interaction of let-7 MicroRNAs with Lin28 , 2011, Cell.
[25] C. Sarrazin,et al. Multi-center evaluation of the Abbott RealTime HCV assay for monitoring patients undergoing antiviral therapy for chronic hepatitis C. , 2011, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[26] R. May,et al. Hepatitis C Virus-Induced Cancer Stem Cell-Like Signatures in Cell Culture and Murine Tumor Xenografts , 2011, Journal of Virology.
[27] Nicola J. Armstrong,et al. Haemolysis during Sample Preparation Alters microRNA Content of Plasma , 2011, PloS one.
[28] A. Kazlauskas. Faculty Opinions recommendation of An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation. , 2010 .
[29] R. Porte,et al. The role of platelets in liver inflammation and regeneration. , 2010, Seminars in thrombosis and hemostasis.
[30] Sun-Mi Park,et al. The role of let-7 in cell differentiation and cancer. , 2010, Endocrine-related cancer.
[31] Y. Shiloh,et al. Accelerated carcinogenesis following liver regeneration is associated with chronic inflammation-induced double-strand DNA breaks , 2010, Proceedings of the National Academy of Sciences.
[32] Kevin Struhl,et al. An Epigenetic Switch Involving NF-κB, Lin28, Let-7 MicroRNA, and IL6 Links Inflammation to Cell Transformation , 2009, Cell.
[33] X. Chen,et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases , 2008, Cell Research.
[34] F. Slack,et al. The let-7 family of microRNAs. , 2008, Trends in cell biology.
[35] Daniel B. Martin,et al. Circulating microRNAs as stable blood-based markers for cancer detection , 2008, Proceedings of the National Academy of Sciences.
[36] Sheng-Nan Lu,et al. A Sustained Virological Response to Interferon or Interferon/Ribavirin Reduces Hepatocellular Carcinoma and Improves Survival in Chronic Hepatitis C: A Nationwide, Multicentre Study in Taiwan , 2006, Antiviral therapy.
[37] G. Petsko. Transformation , 2006, Genome Biology.
[38] M. Lai,et al. Hepatitis C Virus Induces Toll-Like Receptor 4 Expression, Leading to Enhanced Production of Beta Interferon and Interleukin-6 , 2006, Journal of Virology.
[39] C. Burge,et al. Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets , 2005, Cell.
[40] C. Croce,et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[41] Yoshiharu Matsuura,et al. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice , 1998, Nature Medicine.